The Scientific Research and Development team at Prevail Therapeutics is dedicated to discovering and developing innovative gene therapies that target the genetic causes of Parkinson's disease and other neurodegenerative disorders. This team conducts cutting-edge research, performs preclinical studies, and advances the understanding of disease mechanisms to drive the development of effective gene therapy treatments.
View all